These inclusion bodies are thought to play a role in the neuronal dysfunction and cell death found in HD and are a primary target for therapeutic intervention where the prevention of HTT gene expression or improved clearance of mHTT aggregates both serve as theorized potential treatments for the disease. The gene discussed is HTT; the disease is Huntington disease.